Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
IPO News

| More

Laxmi Organic Industries Limited IPO to open on Monday, March 15, 2021

Posted On: 2021-03-09 08:59:47 (Time Zone: Arizona, USA)


Laxmi Organic Industries Limited ("Company" or "Laxmi Organic"), will open the Bid/Offer period in relation to its initial public offering of Equity Shares (the "Offer"/ "IPO") on Monday, March 15, 2021 and close on Wednesday, March 17, 2021. The price band for the Offer has been decided at Rs. 129 - Rs. 130 per Equity Share. The Company may, in consultation with the book running lead managers (the "BRLMs"), consider participation by anchor investors ("Anchor Investors") which shall be one Working Day prior to the Bid/Offer Opening Date, i.e. Friday, March 12, 2021.

The Offer aggregating up to Rs. 600 crore and comprises of a fresh issuance of Equity Shares of up to Rs. 300 crore (the "Fresh Issue") and an offer for sale of Equity Shares up to Rs. 300 crore by promoter selling shareholder, Yellow Stone Trust ("Promoter Selling Shareholder") (the "Offer for Sale", and together with the Fresh Issue, the "Offer").

The Company, in consultation with the BRLMs, undertook a private placement of 15,503,875 Equity Shares aggregating to Rs. 200 crore (the "Pre-IPO Placement"). The size of the Fresh Issue, after the Pre-Ipo placement, has been reduced from Rs. 500 crore to up to Rs. 300 crore and consequently, the Offer Size has been reduced from up to Rs 800 crore million to up to Rs 600 crore.

The Company proposes to utilise the net proceeds towards prepayment or repayment of all or a portion of certain outstanding borrowings availed by the Company; funding the capital expenditure requirements for setting up of a manufacturing facility for fluorospecialty chemicals ("Proposed Facility") pursuant to investment in the wholly owned subsidiary, Yellowstone Fine Chemicals Private Limited ("YFCPL"); investment in YFCPL to fund its working capital requirements; funding capital expenditure required for expansion of the SI Manufacturing Facility ("Proposed Expansion"); funding working capital requirements of the Company; for purchase of plant and machinery in relation to augmenting infrastructural development at its SI Manufacturing Facility, as well as for general corporate purposes. It will be listed on BSE Limited ("BSE") and the National Stock Exchange of India Limited ("NSE").

In terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 31 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the "SEBI ICDR Regulations") and made through the book building process in accordance with Regulation 6(1) of the SEBI ICDR; wherein not more than 50% of the Net Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs", the "QIB Portion"). Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual.

As per the Frost & Sullivan Report, Laxmi Organic is currently among the largest manufacturers of ethyl acetate in India with a market share of approximately 30% of the Indian ethyl acetate market. The Company believes that the diversification of its product portfolio into varied chemistries in Specialty Intermediates has enabled them to create a niche for themselves. Laxmi Organic is the only manufacturer of diketene derivatives in India with a market share of approximately 55% of the Indian diketene derivatives market in terms of revenue in Fiscal 2020 and one of the largest portfolios of diketene products.

The Company has long-standing relationships with marquee customers like Alembic Pharmaceuticals Limited, Dr. Reddy's Laboratories Limited, Hetero Labs Limited, Laurus Labs Limited, Macleods Pharmaceuticals Private Limited, Mylan Laboratories Limited, Neuland Laboratories Limited, Suven Pharmaceuticals, Granules India, UPL Limited and Syngenta Asia Pacific Pte. Ltd. and Sudarshan Chemicals Industries Limited and has significantly expanded its operations and global footprint with customers in more than 30 countries, including China, the Netherlands, Russia, Singapore, the United Arab Emirates, the United Kingdom and the United States of America.

Axis Capital Limited and DAM Capital Advisors Limited (Formerly known as IDFC Securities Limited) are appointed as the Book Running Lead Managers to the Offer ("BRLMs").

All capitalized terms used herein and not specifically defined shall have the same meaning as ascribed to them in the Red Herring Prospectus ("RHP").


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Paras Defence raises Rs. 51 crores from Anchor Investors

Defence and Space Tech Co, Paras becomes most oversubscribed IPO in Capital Markets History

Hyderabad based Consumer Durable Retail Chain, Electronics Mart India files for Rs 500 cr IPO

Hyderabad based Hariom Pipe files for Rs 120 crore IPO

Florintree backed Defence Electronics Co. Data Patterns files for IPO

Paras Defence and Space Technologies Limited's IPO to open on September 21, 2021

Kolkata based Metal and Mining Co., Tega Industries files for its IPO

Prudent Corporate Advisory Services Limited files DRHP with SEBI

Private Market Intelligence SaaS Platform, Tracxn files for an IPO

Inspira Enterprise India Limited files DRHP with SEBI

Aptus Value Housing Finance India Limited, Issue subscribed 0.37 times, Retail portion booked 0.54 times on day 2

Nuvoco's IPO final day: Issue subscribed 1.71 times on final day, Best interest from QIB subscribed 4.23 times

Keventer Agro Limited files DRHP with SEBI

Aptus Value Housing Finance India Limited raises Rs. 834 crs from 21 Anchor Investors

Retail Segment laps up 80 % of CarTrade's IPO on Day 1

Nuvoco sees Steady Retail Category Interest 31% Subscribed on Day 1

Hyderabad based Edible Oil Co., Gemini Edibles & Fats files for Rs. 2500 cr IPO

Nuvoco Vistas raises Rs. 1,500 crores from Anchor Investors, 30% of the IPO size of Rs. 5,000 crores

Exxaro Tiles Limited IPO final day: Issue subscribed 22.57 times, Best interest from Retail investors subscribed 39.88 times

Devyani International Limited IPO Final Day: Issue subscribed 116.71 times, Retail portion booked 39.51

Devyani International Limited Issue subscribed 6.61 times, Retail portion booked 22.94 on day 2

Exxaro Tiles Limited IPO subscribed 10. 30 times, Retail portion booked 21.11 times on day 2

Chemplast Sanmar Limited Initial Public Offer to open on Tuesday, August 10, 2021

Aptus Value Housing Finance India Limited's IPO to open on August 10, 2021

Devyani International Limited Issue subscribed 2.69 times, Retail portion booked 11.36 times on day 1

Exxaro Tiles Limited Issue subscribed 4.67 times, Retail portion booked 9.29 times on day 1

Nuvoco Vistas's Rs. 5,000 crores IPO to open on August 09, 2021

FSN E-Commerce Ventures Private Limited (Nykaa) Files DRHP with SEBI for IPO

Profitable Multi-Channel Auto Platform CarTrade Tech Limited's IPO to open on August 09, 2021

Krsnaa Diagnostics Limited IPO to open on August 4, 2021

Fino Payments Bank becomes the first profitable fintech to file for an IPO

Devyani International Limited's IPO to open on August 04, 2021

Vitrified Tiles Major, Exxaro Tiles Limited's IPO to open on August 04, 2021

Windlas Biotech Limited Initial Public Offer to open on Wednesday, August 04, 2021

ESAF Small Finance Bank files for Rs 998 cr IPO

CarTrade Tech Limited gets SEBI approval to float Rs. 2000 crore IPO

Retail focused HFC, Aptus Value Housing gets SEBI approval for IPO

Glenmark Life Sciences IPO - Top Things to Know

Anand Rathi Wealth Ltd files for Rs 1000 cr IPO

Glenmark Life Sciences Limited IPO to open on July 27, 2021

QSR Player Devyani International gets SEBI approval for IPO

Nuvoco Vistas Corporation Limited gets SEBI approval to float Rs. 5000 crore IPO

Northern Arc Capital Limited plans for IPO files DRHP with SEBI

IPO-Bound Veeda Clinical Research acquires majority stake in Bioneeds preclinical

India's Leading Digital Ecosystem, Paytm files for Rs. 16,600 Crore IPO

Chemspec Chemicals Limited plans for IPO files DRHP with SEBI

Tatva Chintan Pharma Chem Initial Public Offer to open on July 16, 2021

G R Infraprojects Limited IPO oversubscribed by over 100 times

G R Infraprojects Limited Issue subscribed 5.90 times, Retail portion booked 7.49 times on day 2

Zomato Limited IPO to open on July 14, 2021


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020